Premium
Helix Biomedix Inc (PK) (HXBM)
USOTC
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Helix BioMedix is a preclinical biopharmaceutical company focused on drug development for treatment of rare dermatological diseases, such as xeroderma pigmentosum. Our legacy R&D consists of an extensive proprietary library of patented bioactive peptides based on the body's innate immunity many of w... Helix BioMedix is a preclinical biopharmaceutical company focused on drug development for treatment of rare dermatological diseases, such as xeroderma pigmentosum. Our legacy R&D consists of an extensive proprietary library of patented bioactive peptides based on the body's innate immunity many of which the company has outlicensed to partners to commercialize. Helix BioMedix, Inc., is committed to building long term shareholder value through development of novel drugs for rare dermatological conditions with unmet needs and strategic management of our diverse peptide library. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 7.18 | 7.18 | 7.18 | 0 | 0 | CS |
| 12 | -0.01 | -0.139082058414 | 7.19 | 7.19 | 7.18 | 84 | 7.18700599 | CS |
| 26 | -8.42 | -53.9743589744 | 15.6 | 15.6 | 7.18 | 203 | 10.16464691 | CS |
| 52 | -16.09 | -69.1448216588 | 23.27 | 23.5 | 7.18 | 141 | 12.11128094 | CS |
| 156 | -4.8201 | -40.1671652736 | 12.0001 | 26 | 7.18 | 195 | 18.12710141 | CS |
| 260 | -32.82 | -82.05 | 40 | 40 | 7.18 | 222 | 21.57060557 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
